MedPath

Supportive Treatment of Severe Heart Failure by Renal Denervation

Not Applicable
Terminated
Conditions
Heart Failure
Interventions
Procedure: Renal nervous denervation
Registration Number
NCT02638324
Lead Sponsor
Turku University Hospital
Brief Summary

The overactivity of sympathetic nervous system is worsening the hemodynamic state of heart failure patients. The present study is planned to reduce the sympathetic tone in patients with severe heart failure by renal nervous denervation.

Detailed Description

The patient population consists of heart failure patients who are not responding properly to medication and biventricular pacing therapy. The inappropriate response to these therapies is evaluated by patient history (NYHA III-IV), echocardiography (EF \< 45%), 6-minute walking test (\<440m) and measurements of P-ProBNP. The patients who fulfill the inclusion criteria will undergo renal nervous denervation. The patients will be followed up with the same methods as they were recruited to the study (by patient history (NYHA III-IV), echocardiography (EF \< 45%), 6-minute walking test (\<440m) and measurements of P-ProBNP). The overall time of follow-up will be 24 months. The patients are randomised according to the waiting list principle in a manner to 1:1. The waiting time will be 6 months.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • NYHA III-IV
  • ejection fraction <45 %
  • 6-minute walking test under 440m
Exclusion Criteria
  • Unstable hemodynamic state
  • uncooperation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Renal nervous denervation.Renal nervous denervationRenal nervous denervation is performed to the patients who do not response properly to conventional therapy. The patients are randomised according to the waiting list principle.
Renal nervous denervation (delayed)Renal nervous denervationRenal nervous denervation is performed after six months on the waiting list
Primary Outcome Measures
NameTimeMethod
6-minute walking test24 months

Composite outcome measure

Secondary Outcome Measures
NameTimeMethod
Cardiac echocardiography24 months

Composite outcome measure

Patient history24 months

Composite outcome measure

P-proBNP24 months

Composite outcome measure

Trial Locations

Locations (1)

Vaasa Central Hospital

🇫🇮

Vaasa, Finland

© Copyright 2025. All Rights Reserved by MedPath